Holen Sie sich die Stockscreener-App
24.47
2.20%
-0.55
Handel nachbörslich:
24.70
0.23
+0.94%
Schlusskurs vom Vortag:
$25.02
Offen:
$25.17
24-Stunden-Volumen:
2.30M
Relative Volume:
1.77
Marktkapitalisierung:
$1.92B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-32.63
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+4.08%
1M Leistung:
-10.63%
6M Leistung:
-44.94%
1J Leistung:
+6.25%
1-Tages-Spanne:
$24.14
$25.19
1-Wochen-Bereich:
$23.50
$26.11
52-Wochen-Spanne:
$19.73
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
24.47 | 1.96B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
482.16 | 183.07B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
206.85 | 145.32B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
573.07 | 45.56B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.84 | 33.96B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.55 | 33.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
How institutional ownership impacts Veracyte Inc. stockShort-Term Swing Opportunity Summary Sheet - Newser
Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Institutional Momentum and Long-Term Growth? - AInvest
Veracyte's Index Inclusion: A Catalyst for Healthcare's Long-Term Resilience - AInvest
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion - MSN
Is it the right time to buy Veracyte Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance
What are the technical indicators suggesting about Veracyte Inc.Free Wealth Planning Blueprint - jammulinksnews.com
Is Veracyte Inc. a Top Dividend Stock to Watch in 2025Top Gaining Low Risk Assets - metal.it
What are analysts’ price targets for Veracyte Inc. in the next 12 monthsExceptional profit margins - jammulinksnews.com
How strong is Veracyte Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com
Will Veracyte Inc. Stock Benefit from AI and Green Energy TrendsHigh Return Conservative Stocks - metal.it
How does Veracyte Inc. generate profit in a changing economyRobust investment performance - jammulinksnews.com
What is the risk reward ratio of investing in Veracyte Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
What institutional investors are buying Veracyte Inc. stockInvest confidently with proven investment plans - jammulinksnews.com
Why Veracyte Inc. stock attracts strong analyst attentionFree Exclusive Group - Metal.it
What analysts say about Veracyte Inc. stockUnprecedented growth rates - PrintWeekIndia
Veracyte stock soars after S&P SmallCap 600 addition announcement By Investing.com - Investing.com Nigeria
Veracyte stock soars after S&P SmallCap 600 addition announcement - Investing.com
Veracyte Inc. Stock Analysis and ForecastDynamic profit opportunities - PrintWeekIndia
Veracyte jumps after diagnostics company to join S&P 600 Small Cap Index - TradingView
Veracyte Set to Join S&P SmallCap 600 | VCYT Stock News - GuruFocus
Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Small-Cap Healthcare Innovation - AInvest
Veracyte Set to Join S&P SmallCap 600 - 富途牛牛
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel - 富途牛牛
What drives Veracyte Inc. stock pricePhenomenal investment performance - Autocar Professional
Is Veracyte Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
Published on: 2025-07-22 20:34:08 - jammulinksnews.com
CSBR names Veracyte exec Robert Brainin CEO; 700K option package | DNN SEC FilingForm 6-K - Stock Titan
Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st
Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Should You Continue to Hold Veracyte Stock in Your Portfolio Now? - MSN
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):